GlassScriptPhysician profile
Aristides Delahera
NPI 1134177447
$3,780.62
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,064 · 2020: $544 · 2021: $1,029 · 2022: $1,101 · 2023: $43.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $43.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $872.62 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $642.24 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $293.36 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $286.19 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $267.76 | 2019-2022 | |
| Pfizer INC. | $229.43 | 2019-2022 | |
| Preventric Diagnostics, INC. | $148.95 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $143.99 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $142.75 | 2019-2022 | |
| Amgen INC. | $139.56 | 2019-2022 | |
| Esperion Therapeutics, INC. | $111.65 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $108.46 | 2019-2022 | |
| Amarin Pharma, INC. | $79.60 | 2019-2020 | |
| Medtronic Vascular, INC. | $67.42 | 2020 | |
| Sanofi-Aventis U.S. LLC | $54.88 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $31.78 | 2021-2022 | |
| Medtronic, INC. | $28.49 | 2022 | |
| Portola Pharmaceuticals, LLC | $26.03 | 2019 | |
| Abbott Laboratories | $23.00 | 2023 | Cardiomems |
| Allergan, INC. | $22.71 | 2019 | |
| Chiesi USA, INC. | $20.09 | 2020 | |
| Lundbeck LLC | $15.47 | 2019 | |
| Philips North America LLC | $12.94 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aristides Delahera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.